Alpine Immune Sciences Inc (ALPN)
64.60
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
64.60
0.00 (0.00%)
After-Hours: 20:00
Alpine Immune Sciences Free Cash Flow (Quarterly): -19.08M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -19.08M |
September 30, 2023 | -15.80M |
June 30, 2023 | -18.37M |
March 31, 2023 | -26.24M |
December 31, 2022 | -16.90M |
September 30, 2022 | -16.40M |
June 30, 2022 | -16.28M |
March 31, 2022 | 5.423M |
December 31, 2021 | -14.78M |
September 30, 2021 | 30.13M |
June 30, 2021 | -14.71M |
March 31, 2021 | -16.01M |
December 31, 2020 | -9.837M |
September 30, 2020 | -5.452M |
June 30, 2020 | 54.32M |
March 31, 2020 | -9.75M |
December 31, 2019 | -6.157M |
September 30, 2019 | -10.71M |
June 30, 2019 | -7.956M |
March 31, 2019 | -11.34M |
Date | Value |
---|---|
December 31, 2018 | -9.407M |
September 30, 2018 | -7.58M |
June 30, 2018 | -7.375M |
March 31, 2018 | -4.549M |
December 31, 2017 | -5.914M |
September 30, 2017 | 0.382M |
June 30, 2017 | -3.19M |
March 31, 2017 | -8.436M |
December 31, 2016 | -5.193M |
September 30, 2016 | -7.54M |
June 30, 2016 | -6.59M |
March 31, 2016 | -7.042M |
December 31, 2015 | -5.447M |
September 30, 2015 | -5.781M |
June 30, 2015 | -3.22M |
March 31, 2015 | -4.947M |
December 31, 2014 | -3.169M |
September 30, 2014 | -3.121M |
June 30, 2014 | -3.525M |
March 31, 2014 | -4.637M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-26.24M
Minimum
Mar 2023
54.32M
Maximum
Jun 2020
-7.083M
Average
-14.71M
Median
Jun 2021
Free Cash Flow (Quarterly) Benchmarks
Vertex Pharmaceuticals Inc | 118.50M |
Eliem Therapeutics Inc | -0.947M |
Regeneron Pharmaceuticals Inc | 1.351B |
Vera Therapeutics Inc | -25.14M |
Eyenovia Inc | -6.467M |